MAPI Research Trust provides reliable, comprehensive and up-to-date information services to research scientists, pharmaceutical companies, and governmental health agencies involved in the fields of Patient-Reported Outcomes (PRO) and Epidemiology worldwide.
Home SERVICES Questionnaire Licensing
FiRST (Fibromyalgia Rapid Screening Tool)


Developed by:
Serge Perrot & Didier Bouhassira (France)

Objective: 
To detect fibromyalgia syndrome in patients with diffuse chronic pain.

 

Copyright:
FiRST© Serge Perrot, Didier Bouhassira, REDAR, 2010. All rights reserved.

 

Reference publication:
Development and validation of the Fibromyalgia Rapid Screening Tool (FiRST), Perrot S, Bouhassira D, Fermanian J; Cercle d'Etude de la Douleur en Rhumatologie, Pain. 2010 Aug;150(2):250-6. Epub 2010 May 21


Conditions of use:

1. User Agreement:

User is required to complete and sign a User Agreement in which specific conditions requested by the Authors are detailed.

2. Access fees:

carre6 Authors' royalty fees:

- In any academic research and clinical practice: free of charge

- In commercial clinical studies: 500 €* per study and per existing language-version requested.

- In commercial epidemiologic / observational / marketing studies: 500 €* per study and per existing language-version requested + the following administrative fee:
- Up to 1000 administrations/ reproductions: 2 €* per administration/ reproduction;
- Between 1001 and 2500 administrations/ reproductions: 1.80 €* per administration/ reproduction;
- More than 2500 administrations/ reproductions: 1.60 €* per administration/ reproduction.

 Other specific conditions requested by the Authors are detailed in the User Agreement.

carre6 Distribution fees are requested according to the study design and context of use of the questionnaire:

- In not-funded academic research (1) and individual clinical practice: free of charge

- In funded academic research (2): 300 €* per study + 50 €* per language version

- In commercial studies (3) involving "for-profit" organizations: 800 €* per study + 250 €* per language version

* excluding VAT

(1) Not funded academic research: if the project is not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds then fees are waived.

(2) Funded academic research: projects receiving funding from commerce, government, EU should anticipate paying the corresponding fees.

(3) Commercial studies (industry, CRO, any for-profit companies).


Review copy:


UK English version available for review purpose only. Please click here to access


Contact information:


MAPI Research Trust

27 rue de la Villette
F - 69003 LYON
Tel: +33 4 72 13 65 75
Fax: +33 4 72 13 55 73

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Please have the User Agreement completed, dated and signed and return one original copy to MAPI Research Trust by post. As soon as we receive it, we will process your request.

More information on the FiRST on PROQOLID.


[ BACK ]


 

To access our catalog, please click here.

New questionnaires distributed by MAPI Research Trust

ACCEPT (Chronic Treatment Acceptance Questionnaire)
MAPI SAS / Registrat MAPI (France)

ADRQL (Alzheimer Disease Related Quality of Life)
Black Betty S, Kasper Judith D and Rabins Peter V. - Johns Hopkins Medical INstitutions (USA)

Barthel Index questionnaire
The Maryland State Medical Society - MedChi (USA)

ESS (Epworth Sleepiness Scale) 
Murray W. Johns (Australia)

FIRST (Fibromyalgia Rapid Screening Tool)
Serge Perrot & Didier Bouhassira (France)

PDSS-2 (Parkinson's Disease Sleep Scale)
Ray Chaudhuri (UK) & Claudia Trenkwalder (Germany)

Skindex questionnaire 
Mary-Margaret Chren (USA)

TRIM-D and TRIM-D Device (Treatment Related Impact Measure for Diabetes)
Novo Nordisk (Denmark)